Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Nohla Therapeutics
3167
Nohla Therapeutics
Technology
Biotechnology
Health Care
Medical
Therapeutics
Diagnostics
Health Diagnostics
Nohla is the leading developer of universal donor cell therapies for patients with hematologic malignances and other critical diseases.
Suggest edits
Raised
$99.5M
Follow us
Also headquartered in Seattle
Amazon
GeekWire
Starbucks
Zillow
Amazon Web Services
Redfin
Tableau
Bungie
Bittrex
Gates Foundation
Companies in the same industry
Chordia Therapeutics
Denali Therapeutics
Great Basin
Solulink
Vortech Biosystems
Advanced Accelerator Applications
eTheRNA Immunotherapies
Clearside BioMedical, Inc.
Mersana Therapeutics
Brainvectis
Alexa global traffic share
Twitter followers
Overview
Funding
3
Add info
Latest funding
Show all
$11,000,000
Venture capital (Series B) - 2018
University of Tokyo Edge Capital
Premier Partners
Schroder Adveq
$45,000,000
Venture capital (Series B) - 2018
ARCH Venture Partners
5AM Ventures
Fidelity Management
+4
Team Size
1–10
Employees
I work here
Location
Seattle
,
United States
Headquarters
Explore Seattle
GeekWire
Tech Moves: Nohla Therapeutics hires chief medical officer; Apptio adds to board; and more
Strategy
Funding
$11,000,000
Venture capital (Series B)
FinSMEs
,
GeekWire
Nohla Therapeutics Raises Additional $11M in Second Close of $56M Series B
Funding
Health
$45,000,000
Venture capital (Series B)
FinSMEs
Nohla Therapeutics Closes $45M Series B Financing
Health
Funding
GeekWire
Nohla Therapeutics raises $45M, gets new HQ as it moves novel leukemia treatment closer to market
Health
Funding
GeekWire
Inside Nohla Therapeutics’ new Seattle biotech lab as Gov. Jay Inslee geeks out on science
Science
$43,500,000
Venture capital (Series A)
GeekWire
Fred Hutch spinout Nohla Therapeutics raises $43.5M to develop therapy for Leukemia
Health
Funding
